News
Cardinal Health builds out urology focus with $1.9B deal for Solaris Health
Cardinal Health acquired Solaris Health as it continues to build out its multispecialty management services organization platform. | Cardinal Health MSO platforms will reach about 3,000 providers in 32 states once the Solaris Health deal closes,
Healthcare distributor and services company Cardinal Health (NYSE:CAH) missed Wall Street’s revenue expectations in Q2 CY2025 ...
The healthcare conglomerate handily beat on the bottom line in its latest reported quarter, but that's not what the market was paying attention to.
Cardinal Health will acquire Solaris Health for $1.9 billion, lifting its specialty platform while posting mixed Q4 results ...
Cardinal Health reported steady fourth-quarter results and a stronger profit outlook for 2026, while expanding its specialty ...
Cardinal Health today reported fourth quarter fiscal year 2025 revenues of $60.2 billion, relatively flat compared to the ...
1d
Cardinal Health's $1.9 Billion Urology Bet Sends Shares Sliding -- But Could Spark Long-Term Growth
Cardinal Health is making another big move in specialty healthcare, agreeing to acquire Solaris Health for $1.9 billion. The ...
Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback